Identification of the molecular basis of doxorubicin-induced cardiotoxicity

被引:1476
作者
Zhang, Sui [1 ]
Liu, Xiaobing [2 ,3 ]
Bawa-Khalfe, Tasneem [1 ]
Lu, Long-Sheng [2 ]
Lyu, Yi Lisa [4 ]
Liu, Leroy F. [4 ]
Yeh, Edward T. H. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA
[2] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA
[3] Shanghai Jiao Tong Univ, Dept Vasc Surg, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
TOPOISOMERASE-II-BETA; INDUCED CARDIOMYOPATHY; HEART; GENE; TRANSCRIPTION; EXPRESSION; PREVENTION; PGC-1-BETA; APOPTOSIS; ADULT;
D O I
10.1038/nm.2919
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS). Here we show that cardiomyocyte-specific deletion of Top2b (encoding topoisomerase-II beta) protects cardiomyocytes from doxorubicin-induced DNA double-strand breaks and transcriptome changes that are responsible for defective mitochondrial biogenesis and ROS formation. Furthermore, cardiomyocyte-specific deletion of Top2b protects mice from the development of doxorubicin-induced progressive heart failure, suggesting that doxorubicin-induced cardiotoxicity is mediated by topoisomerase-II beta in cardiomyocytes.
引用
收藏
页码:1639 / +
页数:7
相关论文
共 24 条
[1]   Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α [J].
Arany, Zoltan ;
Novikov, Mikhail ;
Chin, Sherry ;
Ma, Yanhong ;
Rosenzweig, Anthony ;
Spiegelman, Bruce M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) :10086-10091
[2]   Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells [J].
Bawa-Khalfe, Tasneem ;
Cheng, Jinke ;
Wang, Zhengxin ;
Yeh, Edward T. H. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (52) :37341-37349
[3]   DIFFERENT PATTERNS OF GENE-EXPRESSION OF TOPOISOMERASE-II ISOFORMS IN DIFFERENTIATED TISSUES DURING MURINE DEVELOPMENT [J].
CAPRANICO, G ;
TINELLI, S ;
AUSTIN, CA ;
FISHER, ML ;
ZUNINO, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1132 (01) :43-48
[4]   Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes [J].
Force, Thomas ;
Kolaja, Kyle L. .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (02) :111-126
[5]   Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation [J].
Ishii, Kiyo-aki ;
Fumoto, Toshio ;
Iwai, Kazuhiro ;
Takeshita, Sunao ;
Ito, Masako ;
Shimohata, Nobuyuki ;
Aburatani, Hiroyuki ;
Taketani, Shigeru ;
Lelliott, Christopher J. ;
Vidal-Puig, Antonio ;
Ikeda, Kyoji .
NATURE MEDICINE, 2009, 15 (03) :259-266
[6]   A topoisomerase IIβ-mediated dsDNA break required for regulated transcription [J].
Ju, BG ;
Lunyak, VV ;
Perissi, V ;
Garcia-Bassets, I ;
Rose, DW ;
Glass, CK ;
Rosenfeld, MG .
SCIENCE, 2006, 312 (5781) :1798-1802
[7]   Transcriptional coactivators PGC-1α and PGC-1β control overlapping programs required for perinatal maturation of the heart [J].
Lai, Ling ;
Leone, Teresa C. ;
Zechner, Christoph ;
Schaeffer, Paul J. ;
Kelly, Sean M. ;
Flanagan, Daniel P. ;
Medeiros, Denis M. ;
Kovacs, Attila ;
Kelly, Daniel P. .
GENES & DEVELOPMENT, 2008, 22 (14) :1948-1961
[8]  
Liao Ronglih, 2007, V139, P251
[9]   Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane [J].
Lyu, Yi Lisa ;
Kerrigan, John E. ;
Lin, Chao-Po ;
Azarova, Anna M. ;
Tsai, Yuan-Chin ;
Ban, Yi ;
Liu, Leroy F. .
CANCER RESEARCH, 2007, 67 (18) :8839-8846
[10]   Role of topoisomerase IIβ in the expression of developmentally regulated genes [J].
Lyu, Yi Lisa ;
Lin, Chao-Po ;
Azarova, Anna M. ;
Cai, Li ;
Wang, James C. ;
Liu, Leroy F. .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (21) :7929-7941